<DOC>
	<DOCNO>NCT01785147</DOCNO>
	<brief_summary>Clinical study aim ass heavy smoker willing quit smoking efficacy safety profile BP1.4979 smoking cessation total abstinence measure subject diary confirm exhale CO ( abstinent &lt; 10 ppm ) .</brief_summary>
	<brief_title>Efficacy Safety BP1.4979 Smoking Cessation</brief_title>
	<detailed_description>BP1.4979 novel compound promise efficacy smoker assess phase I study . This multicenter , randomize , double blind , placebo control , phase IIb trial parallel group assess safety efficacy BP1.4979 smoker .</detailed_description>
	<criteria>Main inclusion Criteria : smoking history least 10 year subject smoke least 15 cigarette per day time least 30 day selection . already make least 2 attempt stop period abstinence &gt; 3 month previous year FTND ≥ 7 Main exclusion Criteria : significant psychiatric illness mood disorder , assess BDI HAD scale ( A + D ≥ 19 , day selection inclusion ) AUDIT ≥ 8 subject smoking cigar pip exclusively subject take antismoking medication and/ Nicotine Replacement Therapy ( NRT ) previous month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Tobacco addition</keyword>
</DOC>